Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-02-28FDA Approved: GLYBURIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approves the original application for the generic drug glyburide. The applicant is Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceutic…
-
CLINICAL_TRIALS trial_result · 2011-02-24Clinical Trial Update: Efficacy of Insulin Lispro Mix 50/50 Therapy [NA]
This clinical trial update discusses the efficacy of insulin lispro mix 50/50 therapy for type 2 diabetes mellitus, with the current status …
-
CLINICAL_TRIALS trial_result · 2011-02-24Clinical Trial Update: Effects of Alogliptin on Pancreatic Beta Cell Function [NA]
An update on a clinical trial assessing alogliptin's effect on pancreatic beta cell function in type 2 diabetes; the current status of the t…
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: Reducing Sedentary Behaviour in Young Adults at Risk of Diabetes [NA]
This document notes a clinical trial conducted by Loughborough University focused on reducing sedentary behaviour in young adults at risk of…
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV) [Phase 4]
This article reports results from the DURABLE Phase 4 trial assessing the durability of starter insulin regimens in adults with Type 2 diabe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-02-18Clinical Trial Update: Diacerein on Insulin Secretion in Diabetes [Phase 2]
Phase 2 clinical trial evaluating diacerein's effect on insulin secretion in adults with Type 2 Diabetes Mellitus and overweight/obesity has…
-
CLINICAL_TRIALS trial_result · 2011-02-18Clinical Trial Update: Impact of Type 2 Diabetes Peer Counseling on Behavioral, Metabolic, and Health Outcomes Among Latinos [NA]
A completed clinical trial evaluated the impact of peer counseling on behavioral, metabolic, and health outcomes in Latinos with Type 2 diab…
-
CLINICAL_TRIALS trial_result · 2011-02-18Clinical Trial Update: Pharmaceutical Care in Type 2 Diabetes [NA]
The clinical trial investigating pharmaceutical care in Type 2 diabetes has completed. The snippet does not provide results from the study.
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics After High Single Ascending Oral Doses of AZD1656 in T2DM Patients [Phase 1]
This report covers a completed Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics after high single ascen…
-
CLINICAL_TRIALS trial_result · 2011-02-10Clinical Trial Update: A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403 [Phase 1]
A multicenter, open-label Phase 1 study evaluating how renal insufficiency affects the pharmacokinetics of SK 0403 in individuals with Type …
-
FDA approval · 2011-02-07FDA Approved: GLUCOTROL XL — Supplemental Application (Roerig)
The FDA approved a supplemental application for Glucotrol XL (glipizide) submitted by Roerig, indicating a change or addition to the existin…
-
CLINICAL_TRIALS trial_result · 2011-02-07Clinical Trial Update: Quitting Caffeine for Better Glucose Metabolism [Phase 1]
Phase 1 clinical trial evaluating whether quitting caffeine improves glucose metabolism in adults with type 2 diabetes; study is completed.
-
CLINICAL_TRIALS research · 2011-02-04Clinical Trial Update: Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study to identify the optimal renoprotective dose of aliskiren in hypertensive patients wit…
-
CLINICAL_TRIALS trial_result · 2011-02-04Clinical Trial Update: Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old
A completed clinical trial from the University of Campinas characterizes incretinopathy in individuals with Type 2 diabetes diagnosed after …
-
FDA approval · 2011-02-03FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOS (pioglitazone) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS other · 2011-02-02Clinical Trial Update: Pioglitazone Incretin Study [Phase 4]
Phase 4 study of pioglitazone in an incretin therapy context in Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2011-02-01Clinical Trial Update: A Trial of Two Diets for Weight and Diabetes Management [NA]
Clinical trial comparing two dietary interventions for weight management in Type 2 Diabetes Mellitus and obesity has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-31Clinical Trial Update: Initiation and Titration of Amaryl [Phase 4]
Phase 4 clinical trial update on initiating and titrating Amaryl (glimepiride) for type 2 diabetes mellitus; the study status is completed.
-
FDA approval · 2011-01-31FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a generic fixed-dose combination tablet of glipizide and metformin hydrochloride under an Original Application (ANDA) from …
-
CLINICAL_TRIALS trial_result · 2011-01-26Clinical Trial Update: Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 trial assessed adding exenatide to insulin glargine in people with type 2 diabetes, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin [Phase 4]
A Phase 4 clinical trial evaluated switching to a basal insulin regimen with insulin glargine in adults with Type 2 diabetes mellitus previo…
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin) [Phase 4]
A Phase 4 trial comparing adding a sulfonylurea versus metformin to insulin glargine in Type 2 Diabetes Mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug naïve Type 2 Diabetes Patients in Korea
The update discusses findings from a completed study indicating insulin resistance as the primary pathogenesis in newly diagnosed, drug-naïv…
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Use of MCT Oil for Enhancement of Weight Loss and Glycemic Control in Obese Diabetic Patients [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial evaluating medium-chain triglyceride (MCT) oil for weight loss and glycemic control in obese indi…
-
CLINICAL_TRIALS trial_result · 2011-01-21Clinical Trial Update: A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise [Phase 3]
A Phase 3 trial evaluating saxagliptin in adults with type 2 diabetes not controlled by diet and exercise has completed, with results posted…